68 ML Tecartus 1471000 CELLS/ML Injection

RxCUI: 2572005
RxNorm name: 68 ML Tecartus 1471000 CELLS/ML Injection
Display name: 68 ML Tecartus 1471000 CELLS/ML Injection
Full name: 68 ML Tecartus 1471000 CELLS/ML Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:11

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125703	Tecartus	Brexucabtagene Autoleucel	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TECARTUS	BREXUCABTAGENE AUTOLEUCEL	Kite Pharma, Inc.	a16108c2-7ca7-45af-965e-54bda4713022	2026-06-16	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2572005

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
a16108c2-7ca7-45af-965e-54bda4713022	68 ML Tecartus 1471000 CELLS/ML Injection	SY	16	These highlights do not include all the information needed to use TECARTUS safely and effectively. See full prescribing information for TECARTUS. TECARTUS ® (brexucabtagene autoleucel) suspension for intravenous infusion Initial U.S. Approval: 2020	20260401
a16108c2-7ca7-45af-965e-54bda4713022	68 ML brexucabtagene autoleucel 1471000 CELLS/ML Injection [Tecartus]	SBD	16	These highlights do not include all the information needed to use TECARTUS safely and effectively. See full prescribing information for TECARTUS. TECARTUS ® (brexucabtagene autoleucel) suspension for intravenous infusion Initial U.S. Approval: 2020	20260401
a16108c2-7ca7-45af-965e-54bda4713022	Tecartus 100,000,000 CELLS in 68 ML Injection	PSN	16	These highlights do not include all the information needed to use TECARTUS safely and effectively. See full prescribing information for TECARTUS. TECARTUS ® (brexucabtagene autoleucel) suspension for intravenous infusion Initial U.S. Approval: 2020	20260401
a16108c2-7ca7-45af-965e-54bda4713022	Tecartus 100,000,000 CELLS per 68 ML Injection	SY	16	These highlights do not include all the information needed to use TECARTUS safely and effectively. See full prescribing information for TECARTUS. TECARTUS ® (brexucabtagene autoleucel) suspension for intravenous infusion Initial U.S. Approval: 2020	20260401